An 83−year−old woman presented with a history of dysphagia and a 10−kg weight loss over a 6−month period. On endosco− py, multiple glassy−looking polyps were seen in the upper and middle thirds of the esophagus (Figure 1 a) . No Barretts metaplasia was observed in the distal esophagus. Biopsy specimens taken from the polyps revealed multifocal adenocar− cinoma originating from the ducts of esophageal mucus glands. The lesions showed extensive mucus production and were located mainly in the submucosal layer, undermining non−neoplastic squa− mous epithelium (Figure 1 b ). There were micropapillary in−situ formations as well as foci of overt, infiltrating, poorly differ− entiated cancer (Figure 1 c) . The patient refused further evaluation and therapy.
Ten months later she presented again with dysphagia. The tumor had progres− sed to cause almost complete luminal obstruction, with coalescing, exophytic, friable masses throughout the entire esophagus, with infiltration of the gastric cardia (Figure 1 d) . Computed tomog− raphy showed that there were multiple metastases to regional lymph nodes, the lungs, and bone. The patients general condition worsened rapidly and she died 11 months after the primary diagnosis.
The vast majority of adenocarcinomas of the esophagus arise in the lower third, within a segment of Barretts mucosa. Salivary−type adenocarcinomas originat− ing from submucosal esophageal glands are extremely rare [1] . It has been argued, however, that the true incidence of these tumors is higher than has been reported because of missed diagnoses due to endo− scopic tissue sampling [2] . Because of the rarity of the disease, the impact of treat− ment on survival is difficult to assess. Lo− cal ablative therapy and radiotherapy might offer palliation of dysphagia in pa− tients with advanced disease [3] .
Most esophageal salivary−type malignan− cies are adenoid−cystic and mucoepider− moid carcinomas [1]. Our case did not fit into either category and had to be classi− fied as "adenocarcinoma of salivary duct origin, not otherwise specified (NOS)". The multifocal growth along the entire or− gan in this case is a tumor feature that has not been described before. 
